Daniel Grosslight
Stock Analyst at Citigroup
(1.17)
# 3,477
Out of 4,732 analysts
105
Total ratings
31.67%
Success rate
-11.57%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintains: Neutral | $120 → $129 | $126.27 | +2.16% | 5 | Jan 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $10.00 | +80.00% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.57 | +36.76% | 7 | Jan 10, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $11 → $10 | $5.49 | +82.15% | 8 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $592.57 | +14.25% | 7 | Jan 10, 2025 | |
| MPLN MultiPlan | Maintains: Neutral | $10 → $13 | $16.07 | -22.22% | 9 | Jan 10, 2025 | |
| PHR Phreesia | Maintains: Buy | $31 → $35 | $27.21 | +28.63% | 6 | Jan 10, 2025 | |
| AGL agilon health | Upgrades: Neutral | $1.75 → $2.25 | $3.09 | -27.18% | 4 | Jan 10, 2025 | |
| HIMS Hims & Hers Health | Downgrades: Sell | $24 → $25 | $27.85 | -10.23% | 7 | Jan 10, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $21 → $19 | $14.58 | +26.89% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $22.24 | +12.41% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $9.4 | $3.61 | +160.39% | 10 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $9.09 | +109.02% | 10 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $10.05 | -0.50% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $11.14 | -28.19% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $4.24 | -70.52% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $3.02 | +15.89% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.52 | +23.57% | 1 | Dec 11, 2019 |
Cardinal Health
Jan 10, 2025
Maintains: Neutral
Price Target: $120 → $129
Current: $126.27
Upside: +2.16%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $10.00
Upside: +80.00%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.57
Upside: +36.76%
Health Catalyst
Jan 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $5.49
Upside: +82.15%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $592.57
Upside: +14.25%
MultiPlan
Jan 10, 2025
Maintains: Neutral
Price Target: $10 → $13
Current: $16.07
Upside: -22.22%
Phreesia
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $27.21
Upside: +28.63%
agilon health
Jan 10, 2025
Upgrades: Neutral
Price Target: $1.75 → $2.25
Current: $3.09
Upside: -27.18%
Hims & Hers Health
Jan 10, 2025
Downgrades: Sell
Price Target: $24 → $25
Current: $27.85
Upside: -10.23%
Owens & Minor
Nov 5, 2024
Maintains: Buy
Price Target: $21 → $19
Current: $14.58
Upside: +26.89%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $22.24
Upside: +12.41%
Apr 16, 2024
Maintains: Neutral
Price Target: $17 → $9.4
Current: $3.61
Upside: +160.39%
Feb 21, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $9.09
Upside: +109.02%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $10.05
Upside: -0.50%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $11.14
Upside: -28.19%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $4.24
Upside: -70.52%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $3.02
Upside: +15.89%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $10.52
Upside: +23.57%